Literature DB >> 8461029

Characterization of recombinant human serotonin 5HT1A receptors expressed in Chinese hamster ovary cells. [3H]spiperone discriminates between the G-protein-coupled and -uncoupled forms.

H Sundaram1, A Newman-Tancredi, P G Strange.   

Abstract

5HT1A serotonin (5-hydroxytryptamine) receptors have been characterized by ligand binding in a recombinant Chinese Hamster Ovary cell line expressing the human receptor gene. The agonist ligand [3H]2-(N,N-dipropylamino)-8-hydroxy-1,2,3,4-tetrahydronaphthalene ([3H]8-OH-DPAT) and the antagonist [3H]spiperone were used. For both radioligands the binding sites labelled have the properties of 5HT1A receptors and most antagonists show roughly equal affinities for the receptors labelled by either [3H]8-OH-DPAT or [3H]spiperone. Agonists, however, show higher affinities for the sites labelled by [3H]8-OH-DPAT and the antagonist spiperone conversely shows a higher affinity for the sites labelled by [3H]spiperone. Whereas [3H]8-OH-DPAT binding is inhibited by guanosine triphosphate (GTP) the binding of [3H]spiperone is increased by GTP. A model is proposed for the results whereby [3H]8-OH-DPAT labels a form of the receptor coupled to a G-protein and [3H]spiperone labels a form of the receptor uncoupled from G-proteins (or possibly coupled to a different G-protein).

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8461029     DOI: 10.1016/0006-2952(93)90243-p

Source DB:  PubMed          Journal:  Biochem Pharmacol        ISSN: 0006-2952            Impact factor:   5.858


  10 in total

1.  [(3)H]-F13640, a novel, selective and high-efficacy serotonin 5-HT(1A) receptor agonist radioligand.

Authors:  Peter Heusler; Christiane Palmier; Stéphanie Tardif; Sophie Bernois; Francis C Colpaert; Didier Cussac
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2010-08-27       Impact factor: 3.000

Review 2.  The serotonin1A receptor: a representative member of the serotonin receptor family.

Authors:  Thomas J Pucadyil; Shanti Kalipatnapu; Amitabha Chattopadhyay
Journal:  Cell Mol Neurobiol       Date:  2005-06       Impact factor: 5.046

Review 3.  Agonist binding, agonist affinity and agonist efficacy at G protein-coupled receptors.

Authors:  P G Strange
Journal:  Br J Pharmacol       Date:  2008-01-28       Impact factor: 8.739

4.  Differential modulation by GTPgammaS of agonist and inverse agonist binding to h5-HT(1A) receptors revealed by [3H]-WAY100,635.

Authors:  A Newman-Tancredi; L Verrièle; M J Millan
Journal:  Br J Pharmacol       Date:  2001-01       Impact factor: 8.739

5.  Alkylation of [3H]8-OH-DPAT binding sites in rat cerebral cortex and hippocampus.

Authors:  E K Nénonéné; F Radja; M Carli; N M van Gelder; S Afkhami-Dastjerdian; T A Reader
Journal:  Neurochem Res       Date:  1996-02       Impact factor: 3.996

6.  Development of CNS multi-receptor ligands: Modification of known D2 pharmacophores.

Authors:  Jagan R Etukala; Xue Y Zhu; Suresh V K Eyunni; Edem K Onyameh; Edward Ofori; Barbara A Bricker; Hye J Kang; Xi-Ping Huang; Bryan L Roth; Seth Y Ablordeppey
Journal:  Bioorg Med Chem       Date:  2016-06-04       Impact factor: 3.641

7.  Guinea pig hippocampal 5-HT(1E) receptors: a tool for selective drug development.

Authors:  Michael T Klein; Milt Teitler
Journal:  J Neurochem       Date:  2009-02-05       Impact factor: 5.372

8.  Metal ion and guanine nucleotide modulations of agonist interaction in G-protein-coupled serotonin1A receptors from bovine hippocampus.

Authors:  K G Harikumar; A Chattopadhyay
Journal:  Cell Mol Neurobiol       Date:  1998-10       Impact factor: 5.046

9.  G-protein-coupled receptors: past, present and future.

Authors:  Stephen J Hill
Journal:  Br J Pharmacol       Date:  2006-01       Impact factor: 8.739

10.  Dual inhibitory action of trazodone on dorsal raphe serotonergic neurons through 5-HT1A receptor partial agonism and α1-adrenoceptor antagonism.

Authors:  Alberto Montalbano; Boris Mlinar; Francesco Bonfiglio; Lorenzo Polenzani; Maurizio Magnani; Renato Corradetti
Journal:  PLoS One       Date:  2019-09-26       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.